Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis

Background: Indicator condition (IC) guided testing for HIV is an effective way to identify undiagnosed people living with HIV, but studies suggest its implementation is lacking. This systematic review provides an overview of the adoption of IC-guided testing in Western countries. Methods: Seven ICs...

Full description

Bibliographic Details
Main Authors: S.J. Bogers, S.H. Hulstein, M.F. Schim van der Loeff, G.J. de Bree, P. Reiss, J.E.A.M van Bergen, S.E. Geerlings
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:EClinicalMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537021001577
_version_ 1818600505309396992
author S.J. Bogers
S.H. Hulstein
M.F. Schim van der Loeff
G.J. de Bree
P. Reiss
J.E.A.M van Bergen
S.E. Geerlings
author_facet S.J. Bogers
S.H. Hulstein
M.F. Schim van der Loeff
G.J. de Bree
P. Reiss
J.E.A.M van Bergen
S.E. Geerlings
author_sort S.J. Bogers
collection DOAJ
description Background: Indicator condition (IC) guided testing for HIV is an effective way to identify undiagnosed people living with HIV, but studies suggest its implementation is lacking. This systematic review provides an overview of the adoption of IC-guided testing in Western countries. Methods: Seven ICs were selected: tuberculosis (TB), malignant lymphoma, hepatitis B, hepatitis C, cervical/vulvar carcinoma/intraepithelial neoplasia grade 2+ (CC/CIN2+, VC/VIN2+), and peripheral neuropathy (PN). Embase and Ovid MEDLINE were searched up to November 20th, 2020. Publications of all types, using data from ≥2009, reporting on HIV test ratios in patients ≥18 years in all settings in Western countries were eligible. HIV test ratios and positivity were reported per IC. A random effects-model for proportions was used to calculate estimated proportions (ES) with 95% CIs. This study was registered at PROSPERO, registration number CRD42020160243. Findings: Fifty-seven references, including 23 full-text articles and 34 other publications were included. Most (28/57) reported on HIV testing in TB. No reports on HIV testing in VC/VIN2+ or PN patients were eligible for inclusion. Large variation in HIV test ratios was observed between and within ICs, resulting from different testing approaches. Highest HIV test ratios (pooled ratio: 0·72, 95%CI 0·63–0·80) and positivity (0·05, 95% CI 0·03–0·06) were observed among TB patients, and lowest among CC/CIN2+ patients (pooled ES test ratio: 0·12, 95%CI 0·01–0·31, positivity: 0·00, 95%CI 0·00–0·00). Interpretation: IC-guided HIV testing is insufficiently implemented in Western countries. The large variation in test ratios provides insight into priority areas for implementing routine IC-guided HIV testing in the future. Funding: HIV Transmission Elimination in Amsterdam (H-TEAM) consortium and Aidsfonds (grant number P-42,702).
first_indexed 2024-12-16T12:36:33Z
format Article
id doaj.art-d77783deb95c4b02830faad21d651c0d
institution Directory Open Access Journal
issn 2589-5370
language English
last_indexed 2024-12-16T12:36:33Z
publishDate 2021-05-01
publisher Elsevier
record_format Article
series EClinicalMedicine
spelling doaj.art-d77783deb95c4b02830faad21d651c0d2022-12-21T22:31:33ZengElsevierEClinicalMedicine2589-53702021-05-0135100877Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysisS.J. Bogers0S.H. Hulstein1M.F. Schim van der Loeff2G.J. de Bree3P. Reiss4J.E.A.M van Bergen5S.E. Geerlings6Department of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, room D3-226, Meibergdreef 9, Amsterdam 1105, Netherlands; Corresponding author.Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, NetherlandsDepartment of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, room D3-226, Meibergdreef 9, Amsterdam 1105, Netherlands; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, NetherlandsDepartment of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, room D3-226, Meibergdreef 9, Amsterdam 1105, NetherlandsDepartment of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, room D3-226, Meibergdreef 9, Amsterdam 1105, Netherlands; Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands; Department of Global Health, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; HIV Monitoring Foundation, Amsterdam, NetherlandsDepartment of General Practice, Amsterdam University Medical Centers, location Academic Medical Center, Netherlands; STI AIDS Netherlands, Amsterdam, NetherlandsDepartment of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, room D3-226, Meibergdreef 9, Amsterdam 1105, NetherlandsBackground: Indicator condition (IC) guided testing for HIV is an effective way to identify undiagnosed people living with HIV, but studies suggest its implementation is lacking. This systematic review provides an overview of the adoption of IC-guided testing in Western countries. Methods: Seven ICs were selected: tuberculosis (TB), malignant lymphoma, hepatitis B, hepatitis C, cervical/vulvar carcinoma/intraepithelial neoplasia grade 2+ (CC/CIN2+, VC/VIN2+), and peripheral neuropathy (PN). Embase and Ovid MEDLINE were searched up to November 20th, 2020. Publications of all types, using data from ≥2009, reporting on HIV test ratios in patients ≥18 years in all settings in Western countries were eligible. HIV test ratios and positivity were reported per IC. A random effects-model for proportions was used to calculate estimated proportions (ES) with 95% CIs. This study was registered at PROSPERO, registration number CRD42020160243. Findings: Fifty-seven references, including 23 full-text articles and 34 other publications were included. Most (28/57) reported on HIV testing in TB. No reports on HIV testing in VC/VIN2+ or PN patients were eligible for inclusion. Large variation in HIV test ratios was observed between and within ICs, resulting from different testing approaches. Highest HIV test ratios (pooled ratio: 0·72, 95%CI 0·63–0·80) and positivity (0·05, 95% CI 0·03–0·06) were observed among TB patients, and lowest among CC/CIN2+ patients (pooled ES test ratio: 0·12, 95%CI 0·01–0·31, positivity: 0·00, 95%CI 0·00–0·00). Interpretation: IC-guided HIV testing is insufficiently implemented in Western countries. The large variation in test ratios provides insight into priority areas for implementing routine IC-guided HIV testing in the future. Funding: HIV Transmission Elimination in Amsterdam (H-TEAM) consortium and Aidsfonds (grant number P-42,702).http://www.sciencedirect.com/science/article/pii/S2589537021001577
spellingShingle S.J. Bogers
S.H. Hulstein
M.F. Schim van der Loeff
G.J. de Bree
P. Reiss
J.E.A.M van Bergen
S.E. Geerlings
Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis
EClinicalMedicine
title Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis
title_full Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis
title_fullStr Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis
title_full_unstemmed Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis
title_short Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis
title_sort current evidence on the adoption of indicator condition guided testing for hiv in western countries a systematic review and meta analysis
url http://www.sciencedirect.com/science/article/pii/S2589537021001577
work_keys_str_mv AT sjbogers currentevidenceontheadoptionofindicatorconditionguidedtestingforhivinwesterncountriesasystematicreviewandmetaanalysis
AT shhulstein currentevidenceontheadoptionofindicatorconditionguidedtestingforhivinwesterncountriesasystematicreviewandmetaanalysis
AT mfschimvanderloeff currentevidenceontheadoptionofindicatorconditionguidedtestingforhivinwesterncountriesasystematicreviewandmetaanalysis
AT gjdebree currentevidenceontheadoptionofindicatorconditionguidedtestingforhivinwesterncountriesasystematicreviewandmetaanalysis
AT preiss currentevidenceontheadoptionofindicatorconditionguidedtestingforhivinwesterncountriesasystematicreviewandmetaanalysis
AT jeamvanbergen currentevidenceontheadoptionofindicatorconditionguidedtestingforhivinwesterncountriesasystematicreviewandmetaanalysis
AT segeerlings currentevidenceontheadoptionofindicatorconditionguidedtestingforhivinwesterncountriesasystematicreviewandmetaanalysis